NO20044145L - Assay for anti-INGAP antistoffer - Google Patents

Assay for anti-INGAP antistoffer

Info

Publication number
NO20044145L
NO20044145L NO20044145A NO20044145A NO20044145L NO 20044145 L NO20044145 L NO 20044145L NO 20044145 A NO20044145 A NO 20044145A NO 20044145 A NO20044145 A NO 20044145A NO 20044145 L NO20044145 L NO 20044145L
Authority
NO
Norway
Prior art keywords
ingap
antibodies
assay
ingap antibodies
Prior art date
Application number
NO20044145A
Other languages
English (en)
Inventor
Aaron I Vinik
David A Taylor-Fischwick
Original Assignee
Gmp Endotherapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gmp Endotherapeutics Inc filed Critical Gmp Endotherapeutics Inc
Publication of NO20044145L publication Critical patent/NO20044145L/no

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854Immunoglobulins
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701Details
    • G01N2333/4733Acute pancreatitis-associated protein
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701Details
    • G01N2333/474Pancreatic thread protein; Reg protein
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2410/00Assays, e.g. immunoassays or enzyme assays, involving peptides of less than 20 animo acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
NO20044145A 2002-03-01 2004-09-30 Assay for anti-INGAP antistoffer NO20044145L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36104002P 2002-03-01 2002-03-01
PCT/US2003/006221 WO2003074549A2 (en) 2002-03-01 2003-02-28 Assay for anti-ingap antibodies

Publications (1)

Publication Number Publication Date
NO20044145L true NO20044145L (no) 2004-11-30

Family

ID=27789061

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20044145A NO20044145L (no) 2002-03-01 2004-09-30 Assay for anti-INGAP antistoffer

Country Status (17)

Country Link
US (2) US7166439B2 (no)
EP (1) EP1478923A4 (no)
JP (1) JP2005519276A (no)
KR (1) KR20040105738A (no)
CN (1) CN1639572A (no)
AU (1) AU2003216469A1 (no)
BR (1) BR0308095A (no)
CA (1) CA2476979A1 (no)
CO (1) CO5611199A2 (no)
IL (1) IL163580A0 (no)
MA (1) MA27184A1 (no)
MX (1) MXPA04008430A (no)
NO (1) NO20044145L (no)
PL (1) PL373569A1 (no)
RU (1) RU2004129314A (no)
WO (1) WO2003074549A2 (no)
ZA (1) ZA200406877B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006096565A2 (en) * 2005-03-04 2006-09-14 Curedm Inc. Methods and pharmaceutical compositions for treating type 1 diabetes mellitus and other conditions
US20090142338A1 (en) * 2005-03-04 2009-06-04 Curedm, Inc. Methods and Compositions for Treating Type 1 and Type 2 Diabetes Mellitus and Related Conditions
CA2609667C (en) 2005-05-25 2011-02-22 Curedm, Inc. Human proislet peptide, derivatives and analogs thereof, and methods of using same
US8785400B2 (en) * 2006-11-22 2014-07-22 Curedm Group Holdings, Llc Methods and compositions relating to islet cell neogenesis
SI2193142T1 (sl) * 2007-08-30 2015-05-29 Curedm Group Holdings, Llc Sestavek in postopek za uporabo proislet peptidov in analogov le-teh
WO2009049222A1 (en) * 2007-10-12 2009-04-16 Curedm, Inc. Compositions and methods of using the human proislet peptide receptor
WO2009137129A2 (en) * 2008-02-12 2009-11-12 Stc.Unm Rapid detection of anti-chromatin autoantibodies in human serum using a portable electrochemical biosensor
WO2014139182A1 (en) 2013-03-15 2014-09-18 Shenzhen Hightide Biopharmaceutical, Ltd. Compositions and methods of using islet neogenesis peptides and analogs thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0573630A4 (en) * 1991-11-25 1995-07-12 Baxter Diagnostics Inc IMMUNOASSAY USING SYNTHETIC HTLV-II PEPTIDES.
JP4111539B2 (ja) 1995-02-22 2008-07-02 イースタン・ヴァージニア・メディカル・スクール・オブ・ザ・メディカル・カレッジ・オブ・ハンプトン・ローズ 膵島新生に関与するingapタンパク質
US5834590A (en) * 1995-02-22 1998-11-10 Eastern Virginia Medical School Of The Medical College Of Hampton Roads Ingap protein involved in pancreatic islet neogenesis
EP0935804A1 (en) * 1996-10-31 1999-08-18 Dsm N.V. Dielectric, radiation curable coating compositions and metal conductors coated with such coating
US6986994B2 (en) * 2001-01-09 2006-01-17 Gmp Endotherapeutics, Inc. INGAP displacement assays

Also Published As

Publication number Publication date
JP2005519276A (ja) 2005-06-30
US7166439B2 (en) 2007-01-23
CN1639572A (zh) 2005-07-13
WO2003074549A3 (en) 2003-12-18
CA2476979A1 (en) 2003-09-12
KR20040105738A (ko) 2004-12-16
ZA200406877B (en) 2005-04-08
US20070184504A1 (en) 2007-08-09
US20030166031A1 (en) 2003-09-04
AU2003216469A1 (en) 2003-09-16
RU2004129314A (ru) 2005-04-20
PL373569A1 (en) 2005-09-05
IL163580A0 (en) 2005-12-18
MA27184A1 (fr) 2005-01-03
EP1478923A2 (en) 2004-11-24
EP1478923A4 (en) 2005-09-21
MXPA04008430A (es) 2004-11-26
CO5611199A2 (es) 2006-02-28
WO2003074549A2 (en) 2003-09-12
BR0308095A (pt) 2006-01-17

Similar Documents

Publication Publication Date Title
NO20044347L (no) Anti-alfavbeta6-antistoff
DK1599504T3 (da) Modificeret antistof
NO20071430L (no) Anti-OX4OL antistoffer
DK1501856T3 (da) Anti-HER2 antistofvarianter
DE602004022855D1 (de) Interleukin-10-antikörper
DE602004009744D1 (de) Reagenzbehälter
DE60222658D1 (de) Monoklonaler anti-cd-40-antikörper
ATE465180T1 (de) Therapeutische anti-igfr1-antikörper- kombinationen
DE60321740D1 (de) Toner
DE60306080D1 (de) Toner
DK1653844T3 (da) Prionspecifikke peptidreagenser
DE50310866D1 (de) Flanschverbindung
DE10390346D2 (de) Mikrofluidik-System
EE200300569A (et) CD44v6-spetsiifilised antikehad
DE60336882D1 (de) Toner
DK1164375T3 (da) Assay til antitransglutaminaseantistoffer
NO20044145L (no) Assay for anti-INGAP antistoffer
DE60321615D1 (de) Toner
FI20011055A (fi) Heveiiniä sitovat monoklonaaliset vasta-aineet
DE60317022D1 (de) Biosensor
NO20053512D0 (no) IL-8-liknende proteiner
FI20030615A0 (fi) Nanopartikkeli bioaffiniteettimäärityksiin
DE50115802D1 (de) Dafür
DE60327250D1 (de) Modifizierte bace
DK1494693T3 (da) Cripto-specifikke antistoffer

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application